[HTML][HTML] The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …
[HTML][HTML] The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
G Pardo, DE Jones - Journal of Neurology, 2017 - ncbi.nlm.nih.gov
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
G Pardo, DE Jones - Journal of neurology, 2017 - pubmed.ncbi.nlm.nih.gov
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
G Pardo, DE Jones - Journal of Neurology, 2017 - search.proquest.com
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …
[PDF][PDF] The sequence of disease‑modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
G Pardo, DE Jones - 2017 - academia.edu
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new diseasemodifying …
considerably over the last 10 years with the approval of multiple new diseasemodifying …
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
G Pardo, D Jones - Journal of Neurology, 2017 - search.ebscohost.com
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
G Pardo, DE Jones - Journal of Neurology, 2017 - europepmc.org
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
G Pardo, DE Jones - Journal of Neurology, 2017 - europepmc.org
The treatment landscape for relapsing forms of multiple sclerosis (RMS) has expanded
considerably over the last 10 years with the approval of multiple new disease-modifying …
considerably over the last 10 years with the approval of multiple new disease-modifying …